Web-based intervention for managing cancer pain in Asian American breast cancer survivors

Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors

This study is testing a new online program to help Asian American breast cancer survivors manage their pain and depression better.

Quick facts

• Phase: Not applicable
• Study type: Interventional
• Enrollment: 300 (estimated)
• Ages: 18 Years and up
• Sex: Female
• Sponsor: University of Texas at Austin (Academic / other)
• Drugs / interventions: chemotherapy, radiation
• Locations: 1 site (Austin, Texas)
• Trial ID: NCT06085313 on ClinicalTrials.gov

What this trial studies

This study aims to enhance a web-based program called CAPA, designed for cancer pain management, specifically tailored for Asian American breast cancer survivors. The program will be further developed to include components addressing depressive symptoms, which are often overlooked in pain management. The study will involve two phases: the first phase focuses on expert review and usability testing of the new components, while the second phase will evaluate the efficacy of the optimized intervention in improving pain experiences. The goal is to provide a culturally sensitive approach to pain management that considers the unique needs of this population.

Who should consider this trial

Good fit: Ideal candidates for this study are women aged 18 and older who identify as Chinese, Korean, or Japanese, have a history of breast cancer, and are experiencing cancer pain and depressive symptoms.

Not a fit: Patients who are under 18 years old or those diagnosed with breast cancer within the past five years may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve pain management and overall quality of life for Asian American breast cancer survivors experiencing pain and depressive symptoms.

How similar studies have performed: Other studies have shown success with culturally tailored interventions for pain management, indicating potential for this approach to be effective.

Eligibility criteria

Inclusion Criteria:

* women aged 18 years and older who identify as Chinese, Korean, or Japanese;
* have had a breast cancer diagnosis in the past;
* can read and write English, Mandarin (simplified or traditional), Korean, or Japanese;
* have access to the internet through computers or mobile devices (mobile phones and tablets);
* have experienced cancer pain during the past week (at least 1 on a scale from 0 to 5 \[no symptom=0, mild symptom that does not bother=1, somewhat bothering symptom=2, moderate symptom=3, severe symptom=4, and worst possible symptom=5\]);
* have experienced depressive symptoms during the past two weeks (1 to 10 on the Patient Health Questionnaire) which is equivalent to the cut-point of minimal to moderate depression.

Exclusion Criteria:

* less than 18 years old because their cancer experience would be different from that of adults.
* Those who are in treatment or not in treatment, but who were diagnosed with breast cancer within the past five years, will be excluded.
* Those who participated in the PI's pilot studies will be excluded.
* The participants of R33 phase will exclude those in active depression treatment regardless of their level of depression.
* Those without Internet access will be excluded, but those with Internet access through community/group computers will be included.

Where this trial is running

Austin, Texas

• The University of Texas at Austin — Austin, Texas, United States (Recruiting)

Study contacts

• Principal investigator: Eun Ok Im — The University of Texas at Austin
• Study coordinator: Wonshik Chee

Conditions Cancer of Breast; Depressive Symptoms; Cancer Pain